IndraLab

Statements

reach
"In ovarian cancer, UCHL3 deubiquitinates TRAF2 to promote tumor progression [ 10 ], and in prostate cancer, overexpression of UCHL3 inhibits the progression of EMT, thereby significantly promoting cel[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"
35032678
reach
"In highly metastatic prostate PC3 cells, UCH-L3 inhibits the cell migration and invasion but UCH-L3 C95S had no effects, suggesting that the hydrolase activity of UCH-L3 is required to inhibit the met[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"
25194810